Safety of subcutaneous daratumumab in the treatment of plasma-cell disorders: A single-center experience.
Year: 2021
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Stanford Health Care, Stanford University
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3166145298
